Fluxion Biosciences, a developer of automated solutions for cellular analysis in life sciences research and drug discovery, has signed a distribution agreement with Harvard Bioscience. The agreement covers Fluxion’s BioFlux and IonFlux platforms for sale to Harvard Bioscience’s customers in North America.   The BioFlux system is used by researchers for automated, high throughput studies of cell-cell interactions, and complements Harvard Bio’s existing perfusion systems....